NuGEN Technologies Appoints New CEO

San Carlos, CA, Jun 14, 2016

NuGEN Technologies, Inc. today announced the appointment of Nitin Sood as Chief Executive Officer.  He succeeds Elizabeth Hutt who recently left to pursue another opportunity.

Mr. Sood comes to NuGEN from PerkinElmer, where he served as Vice President and General Manager of their life science instruments business spanning a portfolio of products in imaging, detection, tissue pathology, automation and NGS sample prep. Prior to his current role, Mr. Sood was the Chief Executive Officer of Boreal Genomics, a developer of "liquid biopsy" tools for non-invasive detection of tumor mutation profiles. Prior to that, Mr. Sood served as General Manager of the Automation and Electrophoresis business units at Agilent Technologies, where he commercialized several successful products in the sample prep markets. He holds master's degrees in both computer science and molecular biology.

“Nitin’s track record of success, technical expertise, and extensive experience in product  commercialization made him the ideal person to lead NuGEN through its next phase of growth and innovation,” said Jeff Bird, Chairman of NuGEN’s Board of Directors and a Managing Director at Sutter Hill Ventures.

 “NuGEN’s differentiated technology, extensive customer base and innovative pipeline of new products makes this an exciting opportunity for me,” said Mr.  Sood. “I look forward to working with the entire NuGEN team to serve our customers  and support their breakthroughs in both research and diagnostic applications of genomics.”

NuGEN’s products offer rapid and simple workflows for a broad range of next generation DNA and RNA sequencing applications, enabling highly sensitive detection of variants and expression levels from tissues, single cells and liquid biopsies.  NuGEN’s products are used by thousands of scientists worldwide and have been cited in over 2,000 peer-reviewed publications.

About NuGEN Technologies, Inc.

Based in San Carlos, California, NuGEN Technologies, Inc., provides innovative NGS and genomic sample prep products for a broad range of sample types including RNA and DNA from whole tissues, FFPE samples, single cells and liquid biopsies. NuGEN’s products offer rapid and simple workflows designed to reduce time and cost per sample. NuGEN products are used by 1000s of customers in basic research, applied markets and molecular diagnostics. NuGEN products are manufactured under stringent quality controls (ISO 13485). The Tecan Group recently acquired NuGEN Technologies, Inc. to further expand Tecan’s dedicated solutions offering into the new market segment of next-generation sequencing (NGS) reagents. To learn more about NuGEN visit

Media contact

NuGEN Technologies, Inc.,